Mucinous cystadenocarcinoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 25: Line 25:
of ovary
of ovary
| colspan="2" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
| colspan="2" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
|-
|-
| rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
| rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Sign and symptoms'''
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical  
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical  


examination
examination
|-
|-
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
Line 49: Line 49:
of the ovary
of the ovary
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Asymptomatic initially
* Vaginal bleeding
* Abdominal mass
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Increased abdominal girth
| style="background: #F5F5F5; padding: 5px;" |
* Abdominal mass
* Ascities
* Pallor
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 65: Line 71:
carcinoma
carcinoma
|
|
* Ascities
* Abdominal mass
* Abdominal fullness
* Early satiety
* Fatigue
* Bowel obstruction
* Pleural effusion
* Pelvic or abdominal pain
* Venous thromboembolism
* Bloating
* Urinary frequency
|
|
| style="background: #F5F5F5; padding: 5px;" |
* Increased abdominal girth
| style="background: #F5F5F5; padding: 5px;" |
* Abdominal mass
* Ascities
* Pallor
* Lymphadenopathy
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 78: Line 99:
|
|
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 92: Line 111:
!'''Symptoms'''
!'''Symptoms'''
!Physical examination
!Physical examination
! colspan="3" |Lab Findings
!Lab Findings
!US
!US
!CT
!CT
Line 104: Line 123:


of pancreas
of pancreas
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 119: Line 136:
[[Pancreatic pseudocyst|pseudocyst]]
[[Pancreatic pseudocyst|pseudocyst]]
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 135: Line 150:
of pancreas
of pancreas
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 147: Line 160:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 159: Line 170:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 171: Line 180:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
| style="background: #DCDCDC; padding: 5px; text-align: center;" |
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 186: Line 193:
!'''Symptoms'''
!'''Symptoms'''
!Physical examination
!Physical examination
! colspan="3" |Lab 1
!Lab 1
!US
!US
!CT
!CT
Line 194: Line 201:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendicitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendicitis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 211: Line 216:
tumors
tumors
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 225: Line 228:
cyst<ref name="pmid2792684" />
cyst<ref name="pmid2792684" />
|
|
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 15:14, 11 April 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Mucinous cystadenocarcinoma must be differentiated from mucinous cystadenoma, serous cystadenoma, and pseudocyst.

Differentiating Mucinous cystadenocarcinoma from other Diseases

Mucinous cystadenocarcinoma of ovary

  • Mucinous borderline tumor of the ovary
  • Metastatic mucinous carcinoma[1]

Mucinous cystadenocarcinoma of pancreas

Mucinous cystadenocarcinoma of appendix

  • Appendicitis
  • Nonmucinous appendiceal tumors
  • Mesenteric cyst[2][3]
Mucinous

cystadenocarcinoma

of ovary

Clinical manifestations Para-clinical findings Gold standard
Sign and symptoms Physical

examination

Lab Findings Imaging Histopathology
US CT MRI
Mucinous

borderline

tumor

of the ovary

  • Asymptomatic initially
  • Vaginal bleeding
  • Abdominal mass
  • Increased abdominal girth
  • Abdominal mass
  • Ascities
  • Pallor
Metastatic

mucinous

carcinoma

  • Ascities
  • Abdominal mass
  • Abdominal fullness
  • Early satiety
  • Fatigue
  • Bowel obstruction
  • Pleural effusion
  • Pelvic or abdominal pain
  • Venous thromboembolism
  • Bloating
  • Urinary frequency
  • Increased abdominal girth
  • Abdominal mass
  • Ascities
  • Pallor
  • Lymphadenopathy
Mucinous

cystadenocarcinoma of pancreas

Symptoms Physical examination Lab Findings US CT MRI Histopathology Gold standard
Mucinous

cystadenoma

of pancreas

Pancreatic

pseudocyst

Serous

cystadenoma

of pancreas

Mucinous

cystadenocarcinoma of appendix

Symptoms Physical examination Lab 1 US CT MRI Histopathology Gold standard
Appendicitis
Nonmucinous

appendiceal

tumors

Mesenteric

cyst[2]

References

  1. ↑ Ovary Epithelial tumors. Atlasgeneticsoncology (2016).http://atlasgeneticsoncology.org/Tumors/OvaryEpithTumID5230.html Accessed on February 29, 2016
  2. ↑ 2.0 2.1 Hamilton DL, Stormont JM (1989). "The volcano sign of appendiceal mucocele". Gastrointest. Endosc. 35 (5): 453–6. PMID 2792684.
  3. ↑ Raijman I, Leong S, Hassaram S, Marcon NE (March 1994). "Appendiceal mucocele: endoscopic appearance". Endoscopy. 26 (3): 326–8. doi:10.1055/s-2007-1008979. PMID 8076556.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Mucinous_cystadenocarcinoma_differential_diagnosis&oldid=1562796"